Javascript must be enabled to continue!
Structural dynamics of the intrinsically disordered linker region of cardiac troponin T
View through CrossRef
ABSTRACTThe cardiac troponin complex, composed of troponins I, T, and C, plays a central role in regulating the calcium-dependent interactions between myosin and the thin filament. Mutations in troponin can cause cardiomyopathies; however, it is still a major challenge to connect how changes in sequence affect troponin’s function. Recent high-resolution structures of the thin filament revealed critical insights into the structure-function relationship of troponin, but there remain large, unresolved segments of troponin, including the troponin-T linker region that is a hotspot for cardiomyopathy mutations. This linker region is predicted to be intrinsically disordered, with behaviors that are not well described by traditional structural approaches; however, this proposal has not been experimentally verified. Here, we used a combination of single-molecule Förster resonance energy transfer (FRET), molecular dynamics simulations, and functional reconstitution assays to investigate the troponin-T linker region. We show that in the context of both isolated troponin and the fully regulated troponin complex, the linker behaves as a dynamic, intrinsically disordered region. This region undergoes polyampholyte expansion in the presence of high salt and distinct conformational changes during the assembly of the troponin complex. We also examine the ΔE160 hypertrophic cardiomyopathy mutation in the linker and demonstrate that it does not affect the conformational dynamics of the linker, rather it allosterically affects interactions with other troponin complex subunits, leading to increased molecular contractility. Taken together, our data clearly demonstrate the importance of disorder within the troponin-T linker and provide new insights into the molecular mechanisms driving the pathogenesis of cardiomyopathies.SIGNIFICANCE STATEMENTTroponin plays a central role in regulating heart contraction, and mutations in troponin can cause human cardiomyopathies. There are several functionally-significant regions of troponin that have not been structurally resolved, including the troponin T linker region that contains multiple cardiomyopathy mutations. In these unresolved regions, it is not possible to understand how changes in sequence affect function. We used computational and experimental techniques to demonstrate that this linker is dynamic and intrinsically disordered both in isolation and in the fully regulated thin filament. Moreover, we show how a cardiomyopathy mutation in this region affects function via allosteric disruption of intermolecular interactions. Our results highlight the need to consider how key mutations affect troponin disorder rather than the structure-function relationship.
Cold Spring Harbor Laboratory
Title: Structural dynamics of the intrinsically disordered linker region of cardiac troponin T
Description:
ABSTRACTThe cardiac troponin complex, composed of troponins I, T, and C, plays a central role in regulating the calcium-dependent interactions between myosin and the thin filament.
Mutations in troponin can cause cardiomyopathies; however, it is still a major challenge to connect how changes in sequence affect troponin’s function.
Recent high-resolution structures of the thin filament revealed critical insights into the structure-function relationship of troponin, but there remain large, unresolved segments of troponin, including the troponin-T linker region that is a hotspot for cardiomyopathy mutations.
This linker region is predicted to be intrinsically disordered, with behaviors that are not well described by traditional structural approaches; however, this proposal has not been experimentally verified.
Here, we used a combination of single-molecule Förster resonance energy transfer (FRET), molecular dynamics simulations, and functional reconstitution assays to investigate the troponin-T linker region.
We show that in the context of both isolated troponin and the fully regulated troponin complex, the linker behaves as a dynamic, intrinsically disordered region.
This region undergoes polyampholyte expansion in the presence of high salt and distinct conformational changes during the assembly of the troponin complex.
We also examine the ΔE160 hypertrophic cardiomyopathy mutation in the linker and demonstrate that it does not affect the conformational dynamics of the linker, rather it allosterically affects interactions with other troponin complex subunits, leading to increased molecular contractility.
Taken together, our data clearly demonstrate the importance of disorder within the troponin-T linker and provide new insights into the molecular mechanisms driving the pathogenesis of cardiomyopathies.
SIGNIFICANCE STATEMENTTroponin plays a central role in regulating heart contraction, and mutations in troponin can cause human cardiomyopathies.
There are several functionally-significant regions of troponin that have not been structurally resolved, including the troponin T linker region that contains multiple cardiomyopathy mutations.
In these unresolved regions, it is not possible to understand how changes in sequence affect function.
We used computational and experimental techniques to demonstrate that this linker is dynamic and intrinsically disordered both in isolation and in the fully regulated thin filament.
Moreover, we show how a cardiomyopathy mutation in this region affects function via allosteric disruption of intermolecular interactions.
Our results highlight the need to consider how key mutations affect troponin disorder rather than the structure-function relationship.
Related Results
Additional PKA phosphorylation sites in human cardiac troponin I
Additional PKA phosphorylation sites in human cardiac troponin I
We used mass spectrometry to monitor cAMP‐dependent protein kinase catalysed phosphorylation of human cardiac troponin I in vitro. Phosphorylation of isolated troponin I by cAMP‐de...
Phosphorylation of troponin and the effects of interactions between the components of the complex
Phosphorylation of troponin and the effects of interactions between the components of the complex
1. The troponin complex from skeletal muscle contains approximately 1 mol of phosphate/80000g of complex, covalently bound to the troponin T component. 2. On prolonged incubation o...
The phosphorylation of troponin I from cardiac muscle
The phosphorylation of troponin I from cardiac muscle
1. Troponin I isolated from fresh cardiac muscle by affinity chromatography contains about 1.9 mol of covalently bound phosphate/mol. Similar preparations of white-skeletal-muscle ...
Misleading Elevation of Troponin T caused by Polymyositis
Misleading Elevation of Troponin T caused by Polymyositis
Background: Elevations of cardiac enzymes are commonly used to indicate myocardial ischemia, but they can be elevated due to other conditions. Different forms of Troponin (cTnT, sT...
TROPONIN IS INDEPENDENTLY ASSOCIATED WITH DEATH IN PATIENTS WITH COVID: A RETROSPECTIVE STUDY
TROPONIN IS INDEPENDENTLY ASSOCIATED WITH DEATH IN PATIENTS WITH COVID: A RETROSPECTIVE STUDY
AbstractObjectiveWe performed a single-centre retrospective observational study investigating the association between troponin positivity in patients hospitalised with COVID-19 and...
Troponin I and Its Clinical Significance
Troponin I and Its Clinical Significance
Troponin I is one of the regulatory proteins of the troponin complex (troponin I, troponin C and troponin T) found in both cardiac and skeletal muscle. The letter I stands for its ...
Cardiac manifestations of fabry disease in female patients: a single centre experience
Cardiac manifestations of fabry disease in female patients: a single centre experience
Abstract
Introduction
Fabry disease is a lysosomal storage disorder resulting in multisystemic effects due to deposition and acc...
e0447 Combination of conventional biomarkers for risk stratification in non ST elevation acute coronary syndrome
e0447 Combination of conventional biomarkers for risk stratification in non ST elevation acute coronary syndrome
Objective
To investigate the predicting value of electrocardiography (ECG) deviation, plasma levels of troponin I (cTnI) and Combination of conventional biomarker...


